Abstract
Background: The objective of this paper was to measure the private and social benefits resulting from technological advances in fertility treatment. Methods: An empirical model investigates the willingness-to-pay (WTP) for advances in the medical technology of in vitro fertilization (IVF) among the general public and among IVF patients in Israel. Results: The empirical model's findings demonstrate that IVF patients and the general public value medical technology advances and have a positive WTP for it. The average WTP for IVF technology advances, among IVF patients, is US$3116.9 whereas for the general public it is US$2284.4. Conclusion: Available evidence suggests that advances in medical technology have delivered substantial benefits and appear to have contributed to improved wellbeing.
| Original language | English |
|---|---|
| Pages (from-to) | 49-63 |
| Number of pages | 15 |
| Journal | Journal of Comparative Effectiveness Research |
| Volume | 5 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2016 |
Keywords
- assisted reproductive technology
- contingent valuation
- in vitro fertilization
- medical technology
- willingness-to-pay